Covaxin Booster Shown To Neutralise Both Omicron And Delta Variants Of COVID-19: Bharat Biotech

Hyderabad-based Bharat Biotech on Wednesday (12 January) said that the booster dose of its COVAXIN Covid-19 vaccine neutralises both Omicron and Delta variants of the Coronavirus.

"Booster dose of COVAXIN generated robust neutralizing antibody responses against both Omicron and Delta," the company said in a statement.

Bharat Biotech added that 100 per cent of test serum samples showed neutralisation of the Delta variant and more than 90 per cent of test serum samples showed neutralisation of the Omicron variant.

"These data add to the body of evidence that the broad-spectrum mechanism of action of a whole virus inactivated Covid-19 vaccine, like COVAXIN, is a viable option in this continously evolving pandemic" the Company said.

The COVAXIN, which was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), was approved by the World Health Organisation for emergency use in November.

The Covaxin and Serum Institute of India's Covishield together are the most widely used vaccines in the mega COVID-19 vaccination drive in the country.